comparemela.com

Latest Breaking News On - Oystein soug - Page 1 : comparemela.com

Targovax ASA appoints Dr Erik Digman Wiklund as new CEO

/PRNewswire/ Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today.

Targovax to present at upcoming conferences

/PRNewswire/ Targovax ASA today announces that members of its executive management team are invited to present and participate in upcoming conferences..

Targovax ASA: Two abstracts accepted at the SITC Congress

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.